CCL28 was increased in superficial CLNs but not in ILNs, and the blockade of VEGFR3 tyrosine kinase with MAZ51 treatment significantly reduced CCL28 in superficial CLNs after cerebral ischemia (Fig. 4i–l). This evidence concerns the gene CCL28 and Cerebral ischemia.